These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24044238)

  • 1. Most prescribed pharmaceuticals.
    Mod Healthc; 2013 Jul; 43(28):34. PubMed ID: 24044238
    [No Abstract]   [Full Text] [Related]  

  • 2. Most prescribed pharmaceuticals: Ranked by total number of retail prescriptions, 2011 (numbers in millions).
    Mod Healthc; 2012 Oct; 42(44):32. PubMed ID: 23230610
    [No Abstract]   [Full Text] [Related]  

  • 3. Most prescribed pharmaceuticals.
    Mod Healthc; 2014 Apr; 44(14):32. PubMed ID: 24804406
    [No Abstract]   [Full Text] [Related]  

  • 4. Pipelines turn to biotech.
    Lawrence S
    Nat Biotechnol; 2007 Dec; 25(12):1342. PubMed ID: 18066015
    [No Abstract]   [Full Text] [Related]  

  • 5. The cost and availability of prescription drugs--what can we do in Massachusetts?
    Carpenter NW; Kedikoglou S
    Issue Brief (Mass Health Policy Forum); 1999 May; (4):1-41. PubMed ID: 12769091
    [No Abstract]   [Full Text] [Related]  

  • 6. Deconstructing Myogen's market cap.
    Ransom J
    Nat Biotechnol; 2006 Mar; 24(3):227-8. PubMed ID: 16525363
    [No Abstract]   [Full Text] [Related]  

  • 7. Most prescribed pharmaceuticals. Ranked by total number of prescriptions, 2009 (numbers in thousands).
    Mod Healthc; 2010 Aug; 40(33):34. PubMed ID: 20821961
    [No Abstract]   [Full Text] [Related]  

  • 8. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant protein therapeutics--success rates, market trends and values to 2010.
    Pavlou AK; Reichert JM
    Nat Biotechnol; 2004 Dec; 22(12):1513-9. PubMed ID: 15583654
    [No Abstract]   [Full Text] [Related]  

  • 10. The origins of new drugs.
    Kneller R
    Nat Biotechnol; 2005 May; 23(5):529-30. PubMed ID: 15877061
    [No Abstract]   [Full Text] [Related]  

  • 11. How insurers' bargaining power affects drug prices in Medicare Part D.
    Natl Bur Econ Res Bull Aging Health; 2009; (4):1-2. PubMed ID: 20355274
    [No Abstract]   [Full Text] [Related]  

  • 12. Creating alternative incentives for pharmaceutical innovation.
    Lyles A
    Clin Ther; 2006 Jan; 28(1):126-8. PubMed ID: 16490586
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotech drug market steadily expands.
    Lawrence S
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract]   [Full Text] [Related]  

  • 14. National Drug Code: a time for change.
    Puglisi RC
    Hosp Formul; 1975 Dec; 10(12):579-81. PubMed ID: 10316673
    [No Abstract]   [Full Text] [Related]  

  • 15. Raising the bar. Barcoding has the potential to dramatically reduce medication errors.
    Goth G
    Healthc Inform; 2006 Apr; 23(4):38-41. PubMed ID: 16676641
    [No Abstract]   [Full Text] [Related]  

  • 16. 1993 drug dollar volume leaders in hospital pharmacies.
    Gwinn B
    Hosp Pharm; 1994 Apr; 29(4):340-4, 362. PubMed ID: 10171823
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 18. When drugs are in short supply.
    Zurlinden J
    Nurs Spectr (Wash D C); 1999 Feb; 9(4):15-6. PubMed ID: 10542818
    [No Abstract]   [Full Text] [Related]  

  • 19. The drug-potency question.
    Walker JM
    US Navy Med; 1974 Aug; 64(2):26-30. PubMed ID: 4534296
    [No Abstract]   [Full Text] [Related]  

  • 20. Bugs or drugs, tortoises or hares?
    Jacobs T
    Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.